What does CUSIP 00847L100 represent in this 13F holders report?

CUSIP 00847L100 is the security identifier for AGRX - AGILE THERAPEUTICS INC - COM used to aggregate holder disclosures.

How many institutions held AGRX - AGILE THERAPEUTICS INC - COM in Q1 2019?

26 institutional investors reported AGRX - AGILE THERAPEUTICS INC - COM for Q1 2019. Use the holders table for investor-level position and value details.

AGILE THERAPEUTICS INC - COM (AGRX)

CUSIP: 00847L100

Q1 2019 13F Holders as of 31 Mar 2019

Security type / class: Equity / COM
Total 13F shares: 18,537,143
Total 13F value: $27,999,006
Share change: +9,132,298
SEC-reported price per share: $1.51
Number of holders: 26
Value change: +$13,818,988
Number of buys: 12
Number of sells: 8

Security key

00847L100

Report period

Q1 2019

Institutions

Top holders

AGRX full security history Ownership snapshot Full 13F holder table AGILE THERAPEUTICS INC SEC filings AGILE THERAPEUTICS INC company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of AGRX - AGILE THERAPEUTICS INC - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

INVESTOR AB

Disclosed value leader

INVESTOR AB

Comparable rows

0/15

Latest evidence

31 Dec 2018

13F Highest disclosed value: $2,036,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

INVESTOR AB has the largest disclosed position value at $2.04M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens INVESTOR AB's linked filing trail.

Disclosed position value Top 5

INVESTOR AB $2.04M

RENAISSANCE TECHNOLOGIES LLC $1.12M

Vivo Capital, LLC $872K

VANGUARD GROUP INC $404K

Fosun International Ltd $286K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
INVESTOR AB	13F Company 13F	— denominator unverified	$2,036,000 3,510,189 shares	—	31 Dec 2018
RENAISSANCE TECHNOLOGIES LLC	13F Company 13F	— denominator unverified	$1,118,000 1,940,677 shares	—	31 Dec 2018
Vivo Capital, LLC	13F Company 13F	— denominator unverified	$872,000 1,513,975 shares	—	31 Dec 2018
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$404,000 700,992 shares	—	31 Dec 2018
Fosun International Ltd	13F Company 13F	— denominator unverified	$286,000 466,302 shares	—	31 Dec 2018
ACADIAN ASSET MANAGEMENT LLC	13F Company 13F	— denominator unverified	$180,000 313,047 shares	—	31 Dec 2018

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2019

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

18,537,143

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2019 vs Q1 2019 Across Filers

Q1 2019 holders

Holder diff

Investor	Q1 2019 Shares	Q1 2019 Shares	Share Diff	Share Chg %	Q1 2019 value	Q1 2019 value	Value change	Value Chg %